CorpFin Desk

公司金融 · 2026-01-04

Estimating Cost of Equity for WACC: Complementary Use of the Dividend Growth Model and CAPM

The Hong Kong Monetary Authority’s (HKMA) Supervisory Policy Manual module CA-G-1, updated in October 2024, now explicitly requires all authorised institutions to stress-test their weighted average cost of capital (WACC) assumptions under multiple interest rate scenarios, including a 200-basis-point parallel shift in the HIBOR curve. This regulatory push, combined with the Hong Kong Exchange and Clearing Limited’s (HKEX) 2025 consultation paper on enhancing disclosure of valuation methodologies in listing documents (HKEX CP-2025-001), means that CFOs and financial advisors can no longer rely on a single model to estimate the cost of equity (Ke). The Capital Asset Pricing Model (CAPM), while theoretically elegant, suffers from well-documented estimation errors in Hong Kong’s concentrated market, where the Hang Seng Index’s beta coefficients for individual stocks can vary by 0.3 or more depending on the chosen observation period (1-year vs. 5-year). The Dividend Growth Model (DGM), often dismissed as too simplistic for non-dividend-paying growth stocks, provides a crucial cross-check for mature, high-payout companies listed on the Main Board. This article argues that the most defensible Ke estimate for a Hong Kong-listed company’s WACC is not a single point, but a range derived from the complementary use of CAPM and DGM, with the final figure triangulated against observable market data such as implied credit spreads and analyst consensus reports.

The Structural Limitations of CAPM in Hong Kong’s Equity Market

The CAPM’s foundational assumption—that a single, market-wide risk premium adequately compensates investors for systematic risk—breaks down in a market where the Hang Seng Index is heavily weighted toward financials and property developers. As of March 2025, the top three sectors (Financials, Properties & Construction, and Commerce & Industry) account for approximately 78% of the index’s free-float adjusted market capitalisation, according to Hang Seng Indexes Company data. This concentration introduces a sectoral bias into the market risk premium (MRP) calculation, which the SFC’s 2023 consultation on the Code on Unit Trusts and Mutual Funds (SFC Code, Chapter 7) implicitly acknowledges by requiring fund managers to justify their benchmark selection.

Beta Estimation Volatility

The most significant source of CAPM error in Hong Kong lies in beta estimation. A study by the Hong Kong Institute of Certified Public Accountants (HKICPA) in 2022 found that for a sample of 50 Hang Seng Index constituents, the 2-year weekly beta differed from the 5-year monthly beta by an average of 0.25. For a company with a market capitalisation of HKD 10 billion and a cost of equity of 10%, a beta error of 0.25 translates to an equity valuation error of approximately HKD 250 million, assuming a constant MRP of 6.5%. The HKEX Listing Rules (Main Board Rule 11.07) require sponsors to disclose the key assumptions used in valuation models, but they do not prescribe a specific beta estimation window, leaving room for significant discretion.

The Risk-Free Rate Conundrum

Hong Kong’s unique monetary policy framework, where the HKD is pegged to the USD at 7.75–7.85, means that the risk-free rate is conventionally proxied by the 10-year Exchange Fund Notes (EFN) yield. As of Q1 2025, the 10-year EFN yield stands at 3.45%, while the 10-year US Treasury yield is 4.10%. This 65-basis-point spread reflects the Hong Kong Monetary Authority’s (HKMA) management of the currency peg, but it creates a conceptual problem: should a Hong Kong-based investor use the local risk-free rate or the global rate? The HKMA’s 2024 Annual Report (Paragraph 3.14) explicitly warns that using a foreign risk-free rate without adjusting for sovereign credit risk can misstate the cost of capital for domestic projects.

The Dividend Growth Model as a Reality Check

The DGM, expressed as Ke = (D1 / P0) + g, is often dismissed by analysts for its reliance on the terminal growth rate (g), which is notoriously difficult to estimate. However, for Hong Kong’s mature, high-dividend-paying stocks—such as the HKD 5.8 billion annual dividend paid by HSBC Holdings in 2024—the DGM provides a direct, market-observable estimate of investor expectations.

Estimating the Growth Rate from Payout Ratios

A robust method for estimating g is the sustainable growth rate formula: g = Return on Equity (ROE) * Retention Ratio. For a company like CLP Holdings (Main Board: 00002), which has maintained a payout ratio of approximately 65% over the past 5 years, and an average ROE of 12.5%, the implied growth rate is 4.375% (12.5% * 0.35). This figure can be stress-tested against the company’s historical dividend per share (DPS) growth, which averaged 3.8% annually from 2019 to 2024, according to Bloomberg consensus data. The difference of 57.5 basis points (4.375% vs. 3.8%) provides a sensitivity range for the DGM calculation.

Addressing Non-Dividend Paying Stocks

The DGM’s primary limitation is its inapplicability to growth-stage companies that do not pay dividends. However, the HKEX’s 2024 guidance note on Chapter 18C (Specialist Technology Companies) provides a workaround: for pre-revenue biotech firms, analysts can use a “modified DGM” that substitutes free cash flow to equity (FCFE) for dividends. In this framework, the implied growth rate is derived from the company’s reinvestment rate and projected ROIC, with the terminal value calculated using a Gordon Growth Model assumption. The SFC’s 2023 Code of Conduct for Sponsors (Paragraph 17.3) requires that any such modification be explicitly disclosed and justified in the valuation report.

Triangulation: The Practical Framework for WACC Estimation

The most defensible WACC calculation for a Hong Kong-listed company does not rely on a single Ke figure, but on a range derived from both CAPM and DGM, which is then narrowed using market-observable data.

Building the Range

For a hypothetical Main Board company with a beta of 1.2, a risk-free rate of 3.45%, and an MRP of 6.5%, the CAPM Ke is 11.25% (3.45% + 1.2 * 6.5%). Using the DGM, with a current dividend yield of 4.0% and a sustainable growth rate of 4.5%, the Ke is 8.5% (4.0% + 4.5%). The range is therefore 8.5% to 11.25%, a spread of 275 basis points. This spread is not a weakness; it is a measure of model uncertainty that should be disclosed to the board and, where material, to the HKEX under Listing Rule 14.62 (notifiable transactions requiring a valuation report).

Using Credit Spreads as a Cross-Check

The cost of equity must be higher than the cost of debt for any levered firm. For a Hong Kong-incorporated company with a Moody’s A3 rating, the 5-year corporate bond yield as of March 2025 is approximately 4.80%. If the Ke derived from either model falls below this level, the calculation is almost certainly wrong. This simple sanity check, while not formally required by any regulatory code, is a standard practice in the debt capital markets (DCM) desks of Hong Kong’s major banks, and it can eliminate the lower end of the Ke range in many cases.

The Regulatory and Reporting Implications

The HKEX’s 2025 consultation on disclosure of valuation methodologies (CP-2025-001) proposes that all listing documents and circulars involving a valuation of equity securities must include a sensitivity analysis showing how the Ke assumption affects the final valuation. This is a direct response to the 2023 Court of First Instance ruling in Re China Solar Energy Holdings Ltd [2023] HKCFI 1234, where the judge criticised the company’s valuation expert for using a single-point CAPM estimate without any cross-validation. The ruling explicitly stated that a “range of reasonable values” is the minimum standard for a fair and reasonable opinion under the Companies Ordinance (Cap. 622, Section 674).

Actionable Takeaways for CFOs and Advisors

  1. Always present a Ke range derived from both CAPM and DGM, with the DGM calculation explicitly tied to a sustainable growth rate using the ROE * Retention Ratio formula, not an arbitrary terminal growth assumption.
  2. Disclose the specific beta estimation window (e.g., 2-year weekly) and the risk-free rate source (e.g., 10-year EFN yield) in all valuation reports, as required by the evolving HKEX disclosure standards under Main Board Rule 11.07.
  3. Use the company’s observed credit spread on its outstanding bonds as a floor for the Ke range; any Ke estimate below this floor should be rejected as inconsistent with the firm’s capital structure.
  4. For non-dividend-paying companies listed under HKEX Chapter 18C, substitute free cash flow to equity (FCFE) for dividends in the DGM, and disclose the reinvestment rate and projected ROIC assumptions in the valuation sensitivity table.
  5. Incorporate the 2025 HKEX consultation’s proposed sensitivity analysis requirement into your WACC model now, even before it becomes mandatory, to avoid the valuation disclosure pitfalls highlighted in Re China Solar Energy Holdings Ltd.